Advertisement

Phenytoin Injection

[17 June 2016]

Products Affected - Description

Phenytoin sodium injection, Hospira
50 mg/mL, 5 mL ampule, 25 count (NDC 00409-1317-02)
 
Phenytoin sodium injection, West-Ward
50 mg/mL, 2 mL vial, 25 count (NDC 00641-0493-25)

Reason for the Shortage

  • Hospira has phenytoin sodium injection on shortage due to manufacturing delay.
  • X-Gen is no longer marketing phenytoin sodium injection.

Available Products

Phenytoin sodium injection, West-Ward
50 mg/mL, 5 mL vial, 25 count (NDC 00641-2555-45)

Estimated Resupply Dates

  • Hospira has phenytoin sodium 50 mg/mL 5mL ampules on back order and the company cannot estimate a release date.
  • West-Ward has phenytoin sodium 50 mg/mL 2 mL vials on back order and the company estimates a release date of 3rd quarter 2016.

Related Shortages

Updated

June 17, May 2, April 11, February 26 and 22, January 26, 2016; December 15 and 2, 2015, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing